Tarsus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
TARS Tarsus Pharmaceuticals Inc
ESINQ ITT Educational Services Inc
EESE Energy and Environmental Services Inc
TXN Texas Instruments Inc
GTH Genetron Holdings Ltd
$NQAT60LMGBPT Nasdaq Austria Energy Large Mid Cap
FICO Fair Isaac Corp
CBDL Cbd Life Sciences Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
Go

Health Care : Pharmaceuticals |
Company profile

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapeutics. The Company's lead product candidate, TP-03, is an investigational eye drop in Phase III to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Blepharitis (Blephar is a reference to eyelid and itis is a reference to inflammation) is a condition characterized by inflammation of the eyelid margin, redness and ocular irritation, including a specific type of eyelash dandruff called collarettes, which are pathognomonic for Demodex blepharitis. The Company designed TP-03 to target and eradicate the root cause of Demodex blepharitis, Demodex mite infestation. The active pharmaceutical ingredient (API) of TP-03, lotilaner, paralyzes and eradicates mites and other parasites through the inhibition of parasite-specific gamma-aminobutyric acid-gated chloride (GABA-Cl) channels.

Closing Price
$17.32
Day's Change
-0.23 (-1.31%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.10
Day's Low
17.25
Volume
(Light)
Volume:
57,294

10-day average volume:
74,858
57,294
  • Prev Close
    17.55
  • Today's Open
    17.87
  • Day's Range
    17.25-18.10
  • Avg Vol (10-day)
    74.9K
  • Last (time)
    4:00p ET 08/11/22
  • Last (size)
    3.6K
  • 52-Wk Range
    10.80 - 31.00
    LowHigh
  • (10/13/21 - 05/09/22)
    60.37%
  • 70.3%
  • Market Cap
    456.0M
  • Shares Outstanding
    26.3M
  • -2.14
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 79.08
  • (% of float 07/29/22)
    7.97

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.